• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

McKesson Corporation Announces Third-Quarter Fiscal 2023 Earnings Release Date

Share:

January 2, 2023

McKesson Corporation (NYSE: MCK) will release its third-quarter fiscal 2023 financial results after market close on Wednesday, February 1, 2023. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results.

The live webcast will be available on McKesson’s Investor Relations website at http://investor.mckesson.com, along with the company’s earnings release, financial tables and slide presentation.

Source: Biospace

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Wireless EEG Headset Zeto Raises $7.3M in Series A FundingWireless EEG Headset Zeto Raises $7.3M in Series A Funding
  • Axol Bioscience And Censo Biotechnologies Announce MergerAxol Bioscience And Censo Biotechnologies Announce Merger
  • Ride Health’s Medical Transport Coordination Platform Picks up $6.2MRide Health’s Medical Transport Coordination Platform Picks up $6.2M
  • Experity Acquires Reputation Management Platform Calibrater HealthExperity Acquires Reputation Management Platform Calibrater Health
  • Amgen to buy Copenhagen-based Nuevolution for $167 millionAmgen to buy Copenhagen-based Nuevolution for $167 million
  • Syneos Health to Acquire Synteract, a Top CRO Provider to Emerging BiopharmaCombination Enhances Syneos Health’s Industry-Leading Position Across Fast-Growing Small to Mid-Sized CategorySyneos Health to Acquire Synteract, a Top CRO Provider to Emerging BiopharmaCombination Enhances Syneos Health’s Industry-Leading Position Across Fast-Growing Small to Mid-Sized Category
  • Without Ethics, AI Can do More Harm than GoodWithout Ethics, AI Can do More Harm than Good
  • Zosano Pharma Announces Partnership Agreement with EVERSANA to Support the Launch and Commercialization of Qtrypta™Zosano Pharma Announces Partnership Agreement with EVERSANA to Support the Launch and Commercialization of Qtrypta™

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications